Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users
Launched by FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PAZ · Apr 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children and adults with cochlear implants (CIs) experience and enjoy music compared to people with normal hearing. Researchers want to understand the musical skills of CI users by using special questionnaires and a music tool called Meludia. They will also analyze the voices of CI users to see if there is a connection between musical ability and how well they perceive music. This study aims to gather insights that might help improve the quality of life for those with hearing impairments.
To participate, you need to be at least 6 years old and have had a cochlear implant for at least a year. If you’re between 6 and 17 years old, you must have received your implant before turning 3 years old. The study includes individuals with varying types of hearing devices, and all participants must be fluent in Spanish and provide consent. If you join, you will answer questions about your musical experiences and undergo some assessments related to your voice and hearing abilities. This research is important for understanding how cochlear implants can affect musical enjoyment and communication in daily life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum age of 6 years.
- • Patients aged 6-17 years must have been implanted before the age of 3 years (to ensure adequate CI performance).
- • Minimum 12 months experience with the device
- • Indications: unilateral (one CI), bilateral (two CIs), bimodal (one CI in one ear and a hearing aid in the other)
- • At least 80% of electrodes active at the time of assessment.
- • Fluency in Spanish
- • Signed and dated informed consent prior to starting any study procedure.
- Exclusion Criteria:
- • Not meet inclusion criteria.
- • Prelingual or perilingual adults.
- • Disability in addition to hearing impairment (e.g., mental disability).
About Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
The Fundación para la Investigación Biomédica del Hospital Universitario La Paz is a leading clinical research organization dedicated to advancing biomedical science and improving patient care through innovative research initiatives. Affiliated with one of Spain's premier healthcare institutions, this foundation fosters collaboration among healthcare professionals, researchers, and industry partners to facilitate the development of new therapies and medical technologies. By prioritizing rigorous scientific methodologies and ethical standards, the foundation aims to enhance the understanding of complex medical conditions and contribute significantly to the global body of clinical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Luis Lassaletta
Principal Investigator
Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials